CLBIO — Corline Biomedical AB Share News
0.000.00%
- SEK371.09m
- SEK338.10m
- SEK7.65m
Brief: Corline Biomedical Q3 pre-tax loss widens to SEK 1.1 million
Brief: Corline Biomedical: pre-clinical study regarding Renaparin shows very high tolerability
Brief: Corline Biomedical applies for Orphan Drug status for Renaparin at FDA
Brief: Corline Biomedical is applying for assessing Cytoparin as drug in upcoming clinical study
Brief: Corline Biomedical says Corline Pharma connected to AstraZeneca BioVentureHub